These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 29031974)

  • 1. In Situ Monitoring and Modeling of the Solution-Mediated Polymorphic Transformation of Rifampicin: From Form II to Form I.
    Guo N; Hou B; Wang N; Xiao Y; Huang J; Guo Y; Zong S; Hao H
    J Pharm Sci; 2018 Jan; 107(1):344-352. PubMed ID: 29031974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative determination of two polymorphic forms of imatinib mesylate in a drug substance and tablet formulation by X-ray powder diffraction, differential scanning calorimetry and attenuated total reflectance Fourier transform infrared spectroscopy.
    Bellur Atici E; Karlığa B
    J Pharm Biomed Anal; 2015 Oct; 114():330-40. PubMed ID: 26099262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the solubility and dissolution properties of several new rifampicin polymorphs, solvates, and hydrates.
    Henwood SQ; Liebenberg W; Tiedt LR; Lötter AP; de Villiers MM
    Drug Dev Ind Pharm; 2001 Nov; 27(10):1017-30. PubMed ID: 11794804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solid-state characterization and dissolution properties of Fluvastatin sodium salt hydrates.
    Borgmann SH; Bernardi LS; Rauber GS; Oliveira PR; Campos CE; Monti G; Cuffini SL; Cardoso SG
    Pharm Dev Technol; 2013; 18(2):525-34. PubMed ID: 23033850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of amorphous content on dissolution characteristics of rifampicin.
    Panchagnula R; Bhardwaj V
    Drug Dev Ind Pharm; 2008 Jun; 34(6):642-9. PubMed ID: 18568915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of systems with amino-acids and oligosaccharides as modifiers of biopharmaceutical properties of furosemide.
    Miranda JA; Garnero C; Zoppi A; Sterren V; Ayala AP; Longhi MR
    J Pharm Biomed Anal; 2018 Feb; 149():143-150. PubMed ID: 29112903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Very fast dissolving acid carboxymethylcellulose-rifampicin matrix: Development and solid-state characterization.
    Luciani-Giacobbe LC; Ramírez-Rigo MV; Garro-Linck Y; Monti GA; Manzo RH; Olivera ME
    Eur J Pharm Sci; 2017 Jan; 96():398-410. PubMed ID: 27721041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solid-state characterization of rifampicin samples and its biopharmaceutic relevance.
    Agrawal S; Ashokraj Y; Bharatam PV; Pillai O; Panchagnula R
    Eur J Pharm Sci; 2004 Jun; 22(2-3):127-44. PubMed ID: 15158898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation and correlation of the physicochemical properties of carvedilol.
    Alves JM; Prado LD; Rocha HV
    Pharm Dev Technol; 2016 Nov; 21(7):856-866. PubMed ID: 26336079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recrystallization of fluconazole using the supercritical antisolvent (SAS) process.
    Park HJ; Kim MS; Lee S; Kim JS; Woo JS; Park JS; Hwang SJ
    Int J Pharm; 2007 Jan; 328(2):152-60. PubMed ID: 16959448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of gabapentin polymorphs in gabapentin/excipient mixtures using solid state
    Tinmanee R; Larsen SC; Morris KR; Kirsch LE
    J Pharm Biomed Anal; 2017 Nov; 146():29-36. PubMed ID: 28843174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solid-State Characterization of Spironolactone 1/3 Hydrate.
    Lemos Barbosa TW; Doriguetto AC; Benjamim de Araújo M; Bonfilio R
    J Pharm Sci; 2019 Jul; 108(7):2458-2464. PubMed ID: 30853514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study on Enhanced Dissolution of Azilsartan-Loaded Solid Dispersion, Prepared by Combining Wet Milling and Spray-Drying Technologies.
    Lu T; Sun Y; Ding D; Zhang Q; Fan R; He Z; Wang J
    AAPS PharmSciTech; 2017 Feb; 18(2):473-480. PubMed ID: 27116201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Supercritical antisolvent co-precipitation of rifampicin and ethyl cellulose.
    Djerafi R; Swanepoel A; Crampon C; Kalombo L; Labuschagne P; Badens E; Masmoudi Y
    Eur J Pharm Sci; 2017 May; 102():161-171. PubMed ID: 28302396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lisinopril dihydrate: single-crystal x-ray structure and physicochemical characterization of derived solid forms.
    Sorrenti M; Catenacci L; Cruickshank DL; Caira MR
    J Pharm Sci; 2013 Oct; 102(10):3596-603. PubMed ID: 23873413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solid state characterization of azelnidipine-oxalic acid co-crystal and co-amorphous complexes: The effect of different azelnidipine polymorphs.
    Pan Y; Pang W; Lv J; Wang J; Yang C; Guo W
    J Pharm Biomed Anal; 2017 May; 138():302-315. PubMed ID: 28237872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progressive steps of polymorphic transformation of gabapentin polymorphs studied by hot-stage FTIR microspectroscopy.
    Hsu CH; Ke WT; Lin SY
    J Pharm Pharm Sci; 2010; 13(1):67-77. PubMed ID: 20456832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solubility and crystal nucleation in organic solvents of two polymorphs of curcumin.
    Liu J; Svärd M; Hippen P; Rasmuson ÅC
    J Pharm Sci; 2015 Jul; 104(7):2183-9. PubMed ID: 25950658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Raman and thermal analysis of indomethacin/PVP solid dispersion enteric microparticles.
    Fini A; Cavallari C; Ospitali F
    Eur J Pharm Biopharm; 2008 Sep; 70(1):409-20. PubMed ID: 18621516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new polymorph of ciprofloxacin saccharinate: Structural characterization and pharmaceutical profile.
    Singh P; Chadha R
    J Pharm Biomed Anal; 2017 Nov; 146():7-14. PubMed ID: 28841428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.